Improving Development and Distribution of Diagnostic Tests Act

3/13/2024, 5:05 PM

Improving Development and Distribution of Diagnostic Tests Act

This bill requires the Department of Health and Human Services to develop a strategic framework for making diagnostic tests available in the event of chemical, biological, or other threats, including public health emergencies involving infectious diseases.

Bill 118 s 2672, also known as the Improving Development and Distribution of Diagnostic Tests Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to enhance the process of developing and distributing diagnostic tests for various diseases and health conditions.

The bill aims to streamline the approval process for diagnostic tests by providing additional funding and resources to the Food and Drug Administration (FDA) to expedite the review and approval of these tests. This will help ensure that new and innovative diagnostic tests can reach the market more quickly, allowing for earlier detection and treatment of diseases.

Additionally, the bill seeks to improve the coordination between federal agencies, such as the FDA and the Centers for Disease Control and Prevention (CDC), to better track and monitor the distribution of diagnostic tests. This will help prevent shortages and ensure that tests are distributed equitably across the country. Overall, the Improving Development and Distribution of Diagnostic Tests Act is aimed at improving public health by making it easier for healthcare providers to access and use diagnostic tests, ultimately leading to better health outcomes for patients.
Congress
118
Number
S - 2672
Introduced on
2023-07-27
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

7/27/2023
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Improving Development and Distribution of Diagnostic Tests Act

This bill requires the Department of Health and Human Services to develop a strategic framework for making diagnostic tests available in the event of chemical, biological, or other threats, including public health emergencies involving infectious diseases.

Bill 118 s 2672, also known as the Improving Development and Distribution of Diagnostic Tests Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to enhance the process of developing and distributing diagnostic tests for various diseases and health conditions.

The bill aims to streamline the approval process for diagnostic tests by providing additional funding and resources to the Food and Drug Administration (FDA) to expedite the review and approval of these tests. This will help ensure that new and innovative diagnostic tests can reach the market more quickly, allowing for earlier detection and treatment of diseases.

Additionally, the bill seeks to improve the coordination between federal agencies, such as the FDA and the Centers for Disease Control and Prevention (CDC), to better track and monitor the distribution of diagnostic tests. This will help prevent shortages and ensure that tests are distributed equitably across the country. Overall, the Improving Development and Distribution of Diagnostic Tests Act is aimed at improving public health by making it easier for healthcare providers to access and use diagnostic tests, ultimately leading to better health outcomes for patients.
Alternative Names
Official Title as IntroducedA bill to require the Secretary of Health and Human Services to develop a strategic framework to improve the development and distribution of diagnostic tests in response to chemical, biological, radiological, or nuclear threats.
Policy Areas
Health

Comments

Related

Bill Update Alert:  Pandemic and All-Hazards Preparedness and Response Act

Recent Activity

Latest Summary1/13/2025

Improving Development and Distribution of Diagnostic Tests Act

This bill requires the Department of Health and Human Services to develop a strategic framework for making diagnostic tests available in the event of chemical, b...

Latest Action7/27/2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.